[Studies on screening for cholesterol-lowering agents using phenyl- and chromane substituted compounds (author's...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Hypercholesterolemia is a significant risk factor for cardiovascular diseases.
• Development of effective cholesterol-lowering agents is crucial for public health.
• Novel synthetic compounds require rigorous evaluation for therapeutic potential.

Purpose of the Study:

• To screen synthesized phenyl and chromane compounds for hypocholesterolemic activity.
• To identify potent cholesterol-lowering agents from a library of novel chemical entities.
• To compare the efficacy of these compounds against a known agent, CPIB.

Main Methods:

• Synthesis of sixteen phenyl and twenty chromane compounds substituted with various acyl groups.
• Administration of 0.3% of synthesized compounds to male mice fed either a cholesterol-rich or normal basal diet.
• Measurement of serum and liver cholesterol levels after 10 and 31 days of treatment.
• Comparative analysis of cholesterol-lowering effects with CPIB.

Main Results:

• Nine compounds exhibited hypocholesterolemic activity: 3 phenyl compounds (N76009, N76011, N76012) and 6 chromane compounds (N-76-H-23, N-76-H-25, N-76-H-27, N-76-H-35, N-76-H-37, N-76-H-38).
• Compound N-76-H-38 showed the most favorable cholesterol-lowering effect among all tested compounds.
• The study successfully identified several promising candidates for further development as hypocholesterolemic agents.

Conclusions:

• Novel phenyl and chromane derivatives possess significant cholesterol-lowering properties.
• Compound N-76-H-38 is identified as a potent hypocholesterolemic agent warranting further investigation.
• This screening provides a basis for developing new therapeutic strategies against hypercholesterolemia.